JPS5781408A - Permeable local medicine composition - Google Patents

Permeable local medicine composition

Info

Publication number
JPS5781408A
JPS5781408A JP56107574A JP10757481A JPS5781408A JP S5781408 A JPS5781408 A JP S5781408A JP 56107574 A JP56107574 A JP 56107574A JP 10757481 A JP10757481 A JP 10757481A JP S5781408 A JPS5781408 A JP S5781408A
Authority
JP
Japan
Prior art keywords
medicine composition
local medicine
permeable local
permeable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56107574A
Other languages
English (en)
Other versions
JPH0420886B2 (ja
Inventor
Randooru Uiketsuto Richiyaado
Retsukusu Kuupaa Yuujin
Edowaado Ruumansu Moorisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPS5781408A publication Critical patent/JPS5781408A/ja
Publication of JPH0420886B2 publication Critical patent/JPH0420886B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56107574A 1980-07-09 1981-07-09 Permeable local medicine composition Granted JPS5781408A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16716780A 1980-07-09 1980-07-09

Publications (2)

Publication Number Publication Date
JPS5781408A true JPS5781408A (en) 1982-05-21
JPH0420886B2 JPH0420886B2 (ja) 1992-04-07

Family

ID=22606219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56107574A Granted JPS5781408A (en) 1980-07-09 1981-07-09 Permeable local medicine composition

Country Status (8)

Country Link
EP (1) EP0043738B1 (ja)
JP (1) JPS5781408A (ja)
AU (1) AU544969B2 (ja)
CA (1) CA1165240A (ja)
DE (1) DE3172516D1 (ja)
IE (1) IE51377B1 (ja)
NZ (1) NZ197668A (ja)
ZA (1) ZA814650B (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0193541A (ja) * 1987-10-02 1989-04-12 Shiseido Co Ltd 薬剤組成物
JPH023613A (ja) * 1988-02-29 1990-01-09 Pfizer Inc 経皮吸収増強組成物
LT4585B (lt) 1996-10-14 1999-12-27 Kowa Company, Ltd. Vietinis anestetikas išoriniam vartojimui
JPWO2002098396A1 (ja) * 2001-05-31 2004-09-16 久光製薬株式会社 経皮吸収型貼付剤

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2122610B (en) * 1982-05-28 1987-04-01 Eisai Co Ltd A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
CH655656B (ja) * 1982-10-07 1986-05-15
GB8302683D0 (en) * 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
JPS60199822A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
JPS59216825A (ja) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
JPS6013720A (ja) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd 生理的活性剤の吸収促進剤
DE3323832A1 (de) * 1983-07-01 1985-01-03 Troponwerke Gmbh & Co Kg Etofenamat-zubereitung
DE3323833A1 (de) * 1983-07-01 1985-01-03 Troponwerke Gmbh & Co Kg Etofenamat-zubereitung
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4731384A (en) * 1983-07-01 1988-03-15 Troponwerke Gmbh & Co, Kg Etofenamate formulation
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
LU86393A1 (fr) * 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
ES2042564T3 (es) * 1986-06-13 1993-12-16 Procter & Gamble Composiciones por via topica penetrantes mejoradas para aumentar el crecimiento del cabello.
LU86548A1 (fr) * 1986-08-07 1988-03-02 Oreal Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
AU601528B2 (en) † 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
EP0302147A1 (en) * 1987-08-03 1989-02-08 The Procter & Gamble Company Topical tanning compositions
EP0313305A3 (en) 1987-10-22 1990-02-07 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
US5057497A (en) * 1987-11-10 1991-10-15 Calam & Associates, Inc. Oral method for the maintenance of healthy gingival tissues using TRF
US5925372A (en) * 1987-12-16 1999-07-20 Novartis Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US5064654A (en) * 1989-01-11 1991-11-12 Ciba-Geigy Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
CH679119A5 (ja) * 1988-05-13 1991-12-31 Sandoz Ag
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
GR1001303B (el) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Μεθοδος παρασκευης μεσου που περιεχει σαλικυλικο οξυ εναντιον απολεπιστικων νοσων της επιδερμιδας.
WO1990008547A1 (de) * 1989-01-25 1990-08-09 Dr. August Wolff Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Salicylsäurehaltiges mittel gegen schuppende hauterkrankungen
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
JP2865422B2 (ja) * 1989-10-23 1999-03-08 セラテック，インコーポレイテッド イオン浸透療法装置および速度調整膜を用いた方法
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
TW222591B (ja) 1991-08-30 1994-04-21 Procter & Gamble
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
US5814599A (en) * 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
WO1996033706A1 (en) * 1995-04-28 1996-10-31 Pharmetrix, Inc. Compositions and methods for inducing dermal analgesia
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US6041253A (en) * 1995-12-18 2000-03-21 Massachusetts Institute Of Technology Effect of electric field and ultrasound for transdermal drug delivery
US6002961A (en) * 1995-07-25 1999-12-14 Massachusetts Institute Of Technology Transdermal protein delivery using low-frequency sonophoresis
US5947921A (en) * 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
EP1563788B8 (en) 1995-08-29 2015-04-08 Nitto Denko Corporation Microporation of human skin for drug delivery and monitoring applications
WO1998000194A2 (en) 1996-06-28 1998-01-08 Sontra Medical, L.P. Ultrasound enhancement of transdermal transport
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6319913B1 (en) 1997-11-10 2001-11-20 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems
US8287483B2 (en) 1998-01-08 2012-10-16 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ES2283446T3 (es) * 2000-12-22 2007-11-01 DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL Composicion de gel basada en alcohol para el tratamiento del hipogonadismo por administracion transescrotal.
US6509492B1 (en) 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6894078B2 (en) * 2001-09-17 2005-05-17 James G. Castillo Alcohol based topical anesthetic formulation and method
US6795727B2 (en) 2001-10-17 2004-09-21 Pedro Giammarusti Devices and methods for promoting transcutaneous movement of substances
DE10341179A1 (de) † 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
US20060094944A1 (en) 2004-10-28 2006-05-04 Sontra Medical Corporation System and method for analyte sampling and analysis with error correction
EP1848270B1 (en) 2005-02-17 2014-05-21 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
US10137135B2 (en) * 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
NZ580179A (en) 2007-03-07 2011-06-30 Echo Therapeutics Inc Transdermal analyte monitoring systems and methods for analyte detection
DE602008005299D1 (de) 2007-04-27 2011-04-14 Echo Therapeutics Inc Hautpermeationsvorrichtung für Analytenmessung oder transdermale Arzneiabgabe
JP2010534221A (ja) * 2007-07-25 2010-11-04 イクソデス・ゲーエムベーハー ライム病の予防用の局所抗生物質組成物
CA2696632C (en) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
US8658699B2 (en) 2008-05-19 2014-02-25 Massachusetts Institute Of Technology Chemical permeation enhancers enhance nerve blockade by toxins
US8609733B2 (en) 2008-05-19 2013-12-17 Massachusetts Institute Of Technology Sensory-specific local anesthesia and prolonged duration local anesthesia
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US9041541B2 (en) 2010-01-28 2015-05-26 Seventh Sense Biosystems, Inc. Monitoring or feedback systems and methods
JP6078230B2 (ja) 2009-03-02 2017-02-08 セブンス センス バイオシステムズ，インコーポレーテッド 血液サンプリングに関連する技術および装置
US20110288389A9 (en) 2009-03-02 2011-11-24 Seventh Sense Biosystems, Inc. Oxygen sensor
US8827971B2 (en) 2011-04-29 2014-09-09 Seventh Sense Biosystems, Inc. Delivering and/or receiving fluids
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
EP2461813A4 (en) 2009-08-05 2014-02-19 Univ Wake Forest Health Sciences COMPOSITIONS AND METHODS FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS
WO2011163347A2 (en) 2010-06-23 2011-12-29 Seventh Sense Biosystems, Inc. Sampling devices and methods involving relatively little pain
WO2012009613A1 (en) 2010-07-16 2012-01-19 Seventh Sense Biosystems, Inc. Low-pressure environment for fluid transfer devices
US20120039809A1 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
EP2637562B1 (en) 2010-11-09 2016-01-27 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
WO2012149155A1 (en) 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
EP2702406B1 (en) 2011-04-29 2017-06-21 Seventh Sense Biosystems, Inc. Plasma or serum production and removal of fluids under reduced pressure
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
TR201903411T4 (tr) 2013-03-15 2019-04-22 Childrens Medical Ct Corp Uzun süreli lokal anestezi için neosaksitoksin kombinasyon formülasyonları.
US20170186270A1 (en) 2013-08-06 2017-06-29 Patent Investment & Licensing Company Method and system for dispatching casino personnel and tracking interactions with players
PT3124016T (pt) 2015-07-31 2019-12-13 Univ Warszawski Medyczny Composição de emulsão antipsoriática que compreende cefazolina
KR102073726B1 (ko) * 2016-12-29 2020-02-05 주식회사 모다이노칩 복합 소자 및 이를 구비하는 전자기기
KR102053356B1 (ko) * 2018-06-08 2019-12-06 주식회사 모다이노칩 복합 소자의 제조 방법, 이에 의해 제조된 복합 소자 및 이를 구비하는 전자기기

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133800A (en) * 1966-11-10 1968-11-20 Ici Ltd Pharmaceutical compositions
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
DE2514873C2 (de) * 1975-04-05 1983-12-29 Merck Patent Gmbh, 6100 Darmstadt Salbengrundlage
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
US4075353A (en) * 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0193541A (ja) * 1987-10-02 1989-04-12 Shiseido Co Ltd 薬剤組成物
JP2537062B2 (ja) * 1987-10-02 1996-09-25 株式会社資生堂 薬剤組成物
JPH023613A (ja) * 1988-02-29 1990-01-09 Pfizer Inc 経皮吸収増強組成物
LT4585B (lt) 1996-10-14 1999-12-27 Kowa Company, Ltd. Vietinis anestetikas išoriniam vartojimui
JPWO2002098396A1 (ja) * 2001-05-31 2004-09-16 久光製薬株式会社 経皮吸収型貼付剤

Also Published As

Publication number Publication date
IE51377B1 (en) 1986-12-10
CA1165240A (en) 1984-04-10
IE811543L (en) 1982-01-09
NZ197668A (en) 1984-03-16
EP0043738A2 (en) 1982-01-13
ZA814650B (en) 1982-07-28
JPH0420886B2 (ja) 1992-04-07
DE3172516D1 (en) 1985-11-07
EP0043738A3 (en) 1982-09-22
AU544969B2 (en) 1985-06-27
AU7272081A (en) 1982-01-14
EP0043738B1 (en) 1985-10-02

Similar Documents

Publication Publication Date Title
JPS5781408A (en) Permeable local medicine composition
ZA813465B (en) Pharmaceutical composition
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
GB2073026B (en) Cannula
GB2083755B (en) Syringe
DE3161062D1 (en) Nutrient composition
DE3175541D1 (en) Dosage units
JPS56152451A (en) Novel composition
DE3164692D1 (en) Ultraviolet-transmissible composition
JPS5740518A (en) Self-oxidizable composition
GB2084662B (en) Syringe
JPS57103639A (en) Non-refilling type syringe
JPS56139420A (en) Drug
JPS56150012A (en) Isotomic solution medicine
ZA818221B (en) Pharmaceutical compounds
JPS573839A (en) Composition
JPS57119826A (en) Improvement regarding substance treatment
JPS57206615A (en) Medicinal composition containing guanfasin
JPS5772049A (en) Tomograph
MTP884B (en) Pharmaceutical preparationes
EP0051789A3 (en) Therapeutic composition
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
JPS5759941A (en) Composition
ZA813632B (en) Ampoule
JPS5761651A (en) Under treatment composition